Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
 
Sign in
Join now
Published in Gastroenterology and
1 other channel

Journal Scan / Research · January 18, 2021

Characteristics and Outcomes of IBD Patients With COVID-19 on Tofacitinib Therapy

Inflammatory Bowel Diseases

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Amar Naik MD

Inflammatory Bowel Diseases
Characteristics and Outcomes of IBD Patients With COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
Inflamm. Bowel Dis. 2020 Dec 16;[EPub Ahead of Print], M Agrawal, EJ Brenner, X Zhang, I Modesto, J Woolcott, RC Ungaro, JF Colombel, MD Kappelman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated